The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease
Open accessAbstract
Objective To examine the impact of systemic inflammation and serum lipids on cardiovascular disease (CVD) in rheumatoid arthritis (RA). Methods In a population-based RA incident cohort (1987 American College of Rheumatology criteria first met between 1988 and 2007), details were collected of serum lipid measures, erythrocyte sedimentation rates (ESRs), C-reactive protein (CRP) measures and cardiovascular events, including ischaemic heart disease and heart failure. Cox models were used to examine the association of lipids and inflammation with the risk of CVD and mortality, adjusting for age, sex and year of RA incidence. Results The study included 651 patients with RA (mean age 55.8 years, 69% female); 67% were rheumatoid factor positive. ESR was associated with the risk of CVD (HR=1.2 per 10 mm/h increase, 95% CI 1.1 to 1.3). Similar findings, although not statistically significant, were seen with CRP (p=0.07). A significant non-linear association for total cholesterol (TCh) with risk of CVD was found, with 3.3-fold increased risk for TCh <4 mmol/l (95% CI 1.5 to 7.2) and no increased risk of CVD for TCh ≥4 mmol/l (p=0.57). Low low-density lipoprotein cholesterol (LDL <2 mmol/l) was associated with marginally increased risk of CVD (p=0.10); there was no increased risk for LDL ≥2 mmol/l (p=0.76). Conclusion Inflammatory measures (particularly, ESR) are significantly associated with the risk of CVD in RA. Lipids may have paradoxical associations with the risk of CVD in RA, whereby lower TCh and LDL levels are associated with increased cardiovascular risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Arnett, F. C., Edworthy, S. M., Bloch, D. A., Mcshane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,752
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Modeling Survival Data: Extending the Cox Model
Therneau, T. M., & Grambsch, P. M. (2000) · Statistics for Biology and Health · doi:10.1007/978-1-4757-3294-8 · Cited by 8,674
Self-citationAcute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734 · cited 1×
“ESR increases with age and changes relatively slowly, whereas CRP changes rapidly and has a broader range of abnormal values, suggesting that they represent different aspects of inflammation.”
BackgroundRosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Authors/Task Force Members, Graham, I., Atar, D., Borch-Johnsen, K., Boysen, G., Burell, G., Cifkova, R., Dallongeville, J., De Backer, G., Ebrahim, S., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm316 · Cited by 3,753
Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000344393.60303.0a · Cited by 3,641
Hastie, T., & Tibshirani, R. (1986) · Statistical Science · doi:10.1214/ss/1177013604 · Cited by 3,409
The epidemiology of heart failure: The Framingham Study
Ho, K. K. L., Pinsky, J. L., Kannel, W. B., & Levy, D. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90455-a · Cited by 2,247
Graham (2007) · doi:10.1097/01.hjr.0000277983.23934.c9 · Cited by 1,647
Aviña‐Zubieta, J. A., Choi, H. K., Sadatsafavi, M., Etminan, M., Esdaile, J. M., & Lacaille, D. (2008) · Arthritis Care & Research · doi:10.1002/art.24092 · Cited by 1,462
History of the Rochester Epidemiology Project
Melton, L. J. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.3.266 · Cited by 1,443 · cited 1×
“Using the population-based resources of the Rochester Epidemiology Project (REP) medical records linkage system, we performed a retrospective cohort study. The unique features of the REP and its potential for population-based studies have been described previously.”
MethodLaw, M. R., Wald, N. J., & Thompson, S. G. (1994) · BMJ · doi:10.1136/bmj.308.6925.367 · Cited by 1,210
Deswal, A., Petersen, N. J., Feldman, A. M., Young, J. B., White, B. G., & Mann, D. L. (2001) · Circulation · doi:10.1161/01.cir.103.16.2055 · Cited by 1,012
Explaining How “High-Grade” Systemic Inflammation Accelerates Vascular Risk in Rheumatoid Arthritis
Sattar, N., McCarey, D. W., Capell, H., & McInnes, I. B. (2003) · Circulation · doi:10.1161/01.cir.0000099844.31524.05 · Cited by 942
Maradit‐Kremers, H., Crowson, C. S., Nicola, P. J., Ballman, K. V., Roger, V. L., Jacobsen, S. J., & Gabriel, S. E. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20853 · Cited by 927
Self-citationAuthors/Task Force Members: Joep Perk (Chairperson) (Sweden)*, G. D. B. (. (2012) · European Journal of Preventive Cardiology · doi:10.1177/2047487312450228 · Cited by 863
The Patient Record in Epidemiology
Kurland, L. T., & Molgaard, C. A. (1981) · Scientific American · doi:10.1038/scientificamerican1081-54 · Cited by 777
Liu, Y., Coresh, J., Eustace, J. A., Longenecker, J. C., Jaar, B., Fink, N. E., Tracy, R. P., Powe, N. R., & Klag, M. J. (2004) · JAMA · doi:10.1001/jama.291.4.451 · Cited by 777
The risk of congestive heart failure in rheumatoid arthritis: A population‐based study over 46 years
Nicola, P. J., Maradit‐Kremers, H., Roger, V. L., Jacobsen, S. J., Crowson, C. S., Ballman, K. V., & Gabriel, S. E. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20855 · Cited by 483
Self-citationC-Reactive Protein in Heart Failure: Prognostic Value and the Effect of Valsartan
Anand, I. S., Latini, R., Florea, V. G., Kuskowski, M. A., Rector, T., Masson, S., Signorini, S., Mocarelli, P., Hester, A., Glazer, R., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.508465 · Cited by 456
The relationship between cholesterol and survival in patients with chronic heart failure
Rauchhaus, M., Clark, A. L., Doehner, W., Davos, C., Bolger, A., Sharma, R., Coats, A. J. S., & Anker, S. D. (2003) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.07.016 · Cited by 444
Schatz, I. J., Masaki, K., Yano, K., Chen, R., Rodriguez, B. L., & Curb, J. D. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05553-2 · Cited by 426
Patterns of cardiovascular risk in rheumatoid arthritis
Solomon, D. H., Goodson, N. J., Katz, J. N., Weinblatt, M. E., Avorn, J., Setoguchi, S., Canning, C., & Schneeweiss, S. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.050377 · Cited by 412
Horwich, T. B., Hamilton, M. A., MacLellan, W. R., & Fonarow, G. C. (2002) · Journal of Cardiac Failure · doi:10.1054/jcaf.2002.0804216 · Cited by 337
Harris, H. W., Grunfeld, C., Feingold, K. R., & Rapp, J. H. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114765 · Cited by 320
Choy, E., & Sattar, N. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.101964 · Cited by 293
Escalante, A., Haas, R. W., & del Rincón, I. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.14.1624 · Cited by 290
Boers, M., Nurmohamed, M. T., Doelman, C. J. A., Lard, L. R., Verhoeven, A. C., Voskuyl, A. E., Huizinga, T. W. J., van de Stadt, R. J., Dijkmans, B. A. C., & van der Linden, S. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.9.842 · Cited by 283
Graham, I., Atar, D., Borch-Johnsen, K., Boysen, G., Burell, G., Cifkova, R., Dallongeville, J., Backer, G. D., Ebrahim, S., Gjelsvik, B., et al. (2007) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000277984.31558.c4 · Cited by 281
Horwich, T. B., Hamilton, M. A., MacLellan, W. R., & Fonarow, G. C. (2002) · Journal of Cardiac Failure · doi:10.1054/jcaf.2002.126519a · Cited by 279
Georgiadis, A. N., Papavasiliou, E. C., Lourida, E. S., Alamanos, Y., Kostara, C., Tselepis, A. D., & Drosos, A. A. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1952 · Cited by 247
Kremers, H. M., Nicola, P. J., Crowson, C. S., Ballman, K. V., & Gabriel, S. E. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20612 · Cited by 216
Self-citationPopa, C. D., van den Hoogen, F. H. J., Radstake, T. R. D. J., Netea, M. G., Eijsbouts, A. M. M., den Heijer, M., van der Meer, J. W. M., van Riel, P. L. C. M., Stalenhoef, A. F. H., & Barrera, P. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.066191 · Cited by 167
Lipid Profiles in Patients with Rheumatoid Arthritis: Mechanisms and the Impact of Treatment
Steiner, G., & Urowitz, M. B. (2009) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2008.01.015 · Cited by 166
Low Serum Cholesterol and Mortality: Which Is the Cause and Which Is the Effect?
Iribarren, C., REED, D. M., Chen, R., Yano, K., & Dwyer, J. H. (1995) · Circulation · doi:10.1161/01.cir.92.9.2396 · Cited by 147
Semb, A. G., Kvien, T. K., AASTVEIT, A. H., Jungner, I., Pedersen, T. R., Walldius, G., & Holme, I. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.126128 · Cited by 134
Dyslipoproteinemia in the course of active rheumatoid arthritis
Lazarevic, M. B., Vitić, J., Mladenovic, V., Myones, B. L., Skosey, J. L., & Swedler, W. I. (1992) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(92)90017-8 · Cited by 117
Why do people with rheumatoid arthritis still die prematurely?
Gabriel, S. E. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.098038 · Cited by 116
Self-citationMosaterd, A., Deckers, J. W., Hoes, A. W., Nederpel, A., Smeets, A. J., Linker, D. T., & Grobbee, D. E. (1997) · European Journal of Epidemiology · doi:10.1023/a:1007383914444 · Cited by 110
Güder, G., Frantz, S., Bauersachs, J. K., Allolio, B., Wanner, C., Koller, M., Ertl, G., Angermann, C. E., & Störk, S. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.825059 · Cited by 107
Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis
Peters, M. J. L., Vis, M., van Halm, V. P., Wolbink, G., Voskuyl, A. E., Lems, W. F., Dijkmans, B. A. C., Twisk, J. W. R., Koning, M. H. M. T. D., van de Stadt, R. J., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.059691 · Cited by 104
Lipids, lipid modifying agents and cardiovascular risk: a review of the evidence
Preiss, D., & Sattar, N. A. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03490.x · Cited by 91
Graf, J. D., Scherzer, R., Grünfeld, C., & Imboden, J. B. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006242 · Cited by 87
Horwich, T. B., & Fonarow, G. C. (2007) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2007.00346.x · Cited by 75
Rochester Epidemiology Project: a unique resource for research in the rheumatic diseases
Kremers, H. M., Crowson, C. S., & Gabriel, S. E. (2004) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2004.07.010 · Cited by 72
Self-citationToms, T. E., Panoulas, V. F., Douglas, K., Nightingale, P., Smith, J., Griffiths, H. R., Sattar, N. A., Symmons, D. P. M., & Kitas, G. D. (2010) · Angiology · doi:10.1177/0003319710373749 · Cited by 67
Richartz, B. M., Radovančević, B., Frazier, O. H., Vaughn, W. K., & Taegtmeyer, H. (1998) · Cardiology · doi:10.1159/000006785 · Cited by 59
Peters, M. J. L., Voskuyl, A. E., Sattar, N. A., Dijkmans, B. A. C., Smulders, Y. M., & Nurmohamed, M. T. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02220.x · Cited by 57
Statin Therapy in Rheumatoid Arthritis: A Cost-Effectiveness and Value-of-Information Analysis
Bansback, N. J., Ara, R., Ward, S. E., Anis, A. H., & Choi, H. K. (2009) · PharmacoEconomics · doi:10.2165/00019053-200927010-00004 · Cited by 41
Baseline Low-Density Lipoprotein Cholesterol Levels and Outcome in Patients With Heart Failure
Charach, G., George, J., Roth, A., Rogowski, O., Wexler, D., Sheps, D. S., Grosskopf, I., Weintraub, M. S., Keren, G., & Rubinstein, A. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.08.660 · Cited by 36
Targeting cardiovascular risk in rheumatoid arthritis: a dual role for statins
Bisoendial, R. J., Stroes, E. S. G., Kastelein, J. J. P., & Tak, P. P. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.277 · Cited by 29
Cited by
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000625 · Cited by 6,185
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.11.003 · Cited by 2,691
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.11.002 · Cited by 1,751
Kaul, A., Gordon, C., Crow, M. K., Touma, Z., Urowitz, M. B., van Vollenhoven, R., Ruiz-Irastorza, G., & Hughes, G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.39 · Cited by 1,391
Agca, R., Heslinga, S. C., Rollefstad, S., Heslinga, M., McInnes, I. B., Peters, M. J. L., Kvien, T. K., Dougados, M., Radner, H., Atzeni, F., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209775 · Cited by 1,380
Metadata
- Authors
- Myasoedova, E., Crowson, C. S., Kremers, H. M., Roger, V. L., Fitz-Gibbon, P. D., Therneau, T. M., & Gabriel, S. E.
- Venue
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Published
- 2011-03
- Volume
- 70
- Issue
- 3
- Pages
- 482-487
- ISSN
- 0003-4967 (ISSN-L)
- OpenAlex
- W2115067834
- Cited by
- 586
- References
- 56
- FWCI
- 17.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.